Abbott Laboratories
ABT
HK$1,033
Share price
0.10%
Change (1 day)
28.49%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Net assets
Net assets on the balance sheet as of March 2025 : HK$385.14 Billion
According to Abbott Laboratories's latest financial reports the company has HK$385.14 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Abbott Laboratories - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $HK$371.87 B | 22.64% |
| 2023-12-31 | $HK$303.24 B | 5.16% |
| 2022-12-31 | $HK$288.34 B | 2.65% |
| 2021-12-31 | $HK$280.89 B | 9.79% |
| 2020-12-31 | $HK$255.84 B | 4.95% |
| 2019-12-31 | $HK$243.77 B | 1.33% |
| 2018-12-31 | $HK$240.58 B | -0.98% |
| 2017-12-31 | $HK$242.96 B | 51.24% |
| 2016-12-31 | $HK$160.65 B | -2.81% |
| 2015-12-31 | $HK$165.29 B | -1.52% |
| 2014-12-31 | $HK$167.84 B | -14.34% |
| 2013-12-31 | $HK$195.92 B | -5.73% |
| 2012-12-31 | $HK$207.83 B | 9.1% |
| 2011-12-31 | $HK$190.49 B | 7.52% |
| 2010-12-31 | $HK$177.16 B | -0.22% |
| 2009-12-31 | $HK$177.54 B | 31.15% |
| 2008-12-31 | $HK$135.37 B | -2.34% |
| 2007-12-31 | $HK$138.61 B | 26.82% |
| 2006-12-31 | $HK$109.30 B | -2.2% |
| 2005-12-31 | $HK$111.76 B | 0.39% |
| 2004-12-31 | $HK$111.32 B | 9.87% |
| 2003-12-31 | $HK$101.32 B | 21.83% |
| 2002-12-31 | $HK$83.16 B | 17.73% |
| 2001-12-31 | $HK$70.64 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | HK$613.14 B | 59.20% | 🇺🇸 USA |
 Pfizer PFE | HK$711.49 B | 84.73% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | HK$388.45 B | 0.86% | 🇺🇸 USA |
 Hologic HOLX | HK$36.25 B | -90.59% | 🇺🇸 USA |
 Medtronic MDT | HK$378.80 B | -1.65% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | HK$136.96 B | -64.44% | 🇺🇸 USA |
 Boston Scientific BSX | HK$176.19 B | -54.25% | 🇺🇸 USA |
 AstraZeneca AZN | HK$322.87 B | -16.17% | 🇬🇧 UK |
 Novartis NVS | HK$301.84 B | -21.63% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | HK$138.48 B | -64.04% | 🇬🇧 UK |